共 9 条
Orthopaedic Nurse Navigators and Total Joint Arthroplasty Preoperative Optimization Diabetes and Cardiovascular Disease-Part 3 of the Movement Is Life Special ONJ Series
被引:0
|作者:
Kebeh, Martha
[1
]
Dlott, Chloe C.
[1
]
Kurek, Donna
[2
,3
]
Morris, Jensa C.
[4
,5
,6
]
Johnson, Charla B.
[7
]
Wiznia, Daniel H.
[1
]
机构:
[1] Yale Sch Med, Dept Orthopaed & Rehabil, 800 Howard Ave, New Haven, CT 06519 USA
[2] Natl Assoc Orthopaed Nurses & Movement Is Life, Chicago, IL USA
[3] OrthoVirginia, Chesterfield, VA USA
[4] Yale New Haven Hosp, Hosp Med Serv, New Haven, CT USA
[5] Yale New Haven Hosp, Smilow Canc Hosp, New Haven, CT USA
[6] Yale Sch Med, New Haven, CT USA
[7] Franciscan Missionaries Our Lady Hlth Syst, Baton Rouge, LA USA
基金:
美国国家卫生研究院;
关键词:
PRIMARY TOTAL KNEE;
RISK-FACTORS;
MYOCARDIAL-INFARCTION;
HIP-ARTHROPLASTY;
HEMOGLOBIN A1C;
SURGICAL RISK;
MANAGEMENT;
REPLACEMENT;
INFECTION;
MELLITUS;
D O I:
10.1097/NOR.0000000000000997
中图分类号:
R47 [护理学];
学科分类号:
1011 ;
摘要:
Diabetes and cardiovascular disease are some of the most common risk factors for complications after total joint arthroplasty (TJA). Preoperative optimization programs are dependent on nurse navigators for coordination of interventions that improve patients' health and surgical outcomes. This article uses information regarding the current practices for diabetes and cardiovascular disease management to provide recommendations for nurse navigators when managing these risk factors prior to TJA. We consulted nurse navigators and conducted a literature review to learn about strategies for addressing diabetes and cardiovascular disease in preoperative optimization programs. Nurse navigators can play a critical role in addressing these conditions by providing patient education and implementing preoperative optimization protocols that incorporate discussion regarding guidelines for diabetes and cardiovascular disease management prior to surgery. This article shares recommendations and resources for nurse navigators to help address diabetes and cardiovascular disease as part of preoperative optimization programs.
引用
收藏
页码:2 / 9
页数:8
相关论文